“Early immune pathology and persistent dysregulation

New Post Public Reply Private Reply Replies (0) Message Board
CTMedic
1,482
“Early immune pathology and persistent dysregulation characterise severe COVID-19”

Longitudinal analysis of Covid patients in UK, identifying patterns of immune response as predictive of disease course.

Sounds really, really familiar. Further evidence that severe Covid tied to immune dysfunction, specifically lack of sufficient adaptive response (B and T lymphocytes) with continued innate immune response/activation/hyperinflammation.

Doors is open for leronlimab.

https://www.medrxiv.org/content/10.1101/2021....20248765v1



“ The NIHR BioResource has allowed us to address two important questions regarding SARS-CoV-2. Firstly, how does the very early immune response in patients who recovered from disease with few or no symptoms, compare with those who experienced severe disease? And secondly, for those patients who experience severe disease, how rapidly does their immune system recover and how might this relate to ‘long COVID’?”

undefined
Listen to Professor Ken Smith discuss the findings with the Naked Scientists
The team found evidence of an early, robust adaptive immune response in those infected individuals whose disease was asymptomatic or mildly symptomatic. An adaptive immune response is where the immune system identifies an infection and then produces T cells, B cells and antibodies specific to the virus to fight back. These individuals produced the immune components in larger numbers than patients with more severe COVID-19 managed, and within the first week of infection – after which these numbers rapidly returned to normal. There was no evidence in these individuals of systemic inflammation that can lead to damage in multiple organs.

In patients requiring admission to hospital, the early adaptive immune response was delayed, and profound abnormalities in a number of white cell subsets were present. Also present in the first blood sample taken from these patients was evidence of increased inflammation, something not seen in those with asymptomatic or mild disease. This suggests that an abnormal inflammatory component to the immune response is present even around the time of diagnosis in individuals who progress to severe disease.

The team found that key molecular signatures produced in response to inflammation were present in patients admitted to hospital. They say that these signatures could potentially be used to predict the severity of a patient’s disease, as well as correlating with their risk of COVID-19 associated death.”

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kinross Gold Fraud Lawsuit: What Shareholders Need to Know

Updated Category News Views 64

Kinross Gold's Legal Quagmire There's a fresh storm brewing for Kinross Gold Corporation (NYSE: KGC), and it ain't the kind investors enjoy riding. You see, the company is up to its neck in a class action lawsuit, courtesy of Schall, Brown & Schwartz LLP—a big-name shareholder rights litigation outfit. The gripe? Alleged securities fraud, violating §§10(b) and 20(a)...

Continue Reading
Animal Parasite Market Growth Has a Resistance Catch

Updated Category News Views 41

Flea collars and cattle worms do not sound glamorous, yet this is exactly where durable animal-health revenue gets built. Wissen Research puts the global animal parasiticides market at $13.6 billion in 2026 and projects $18.6 billion by 2031, a 6.5% compound annual growth rate. That is respectable, not moonshot stuff, and frankly that is part of the appeal. Pet owners...

Continue Reading
Stand Out For Good Makes a Bold Michigan Avenue Bet

Updated Category News Views 51

A six-floor retail commitment lands with a thud Stand Out For Good is taking on roughly 51,079 square feet at 669 North Michigan Avenue, and nobody should mistake that for a casual expansion. Six levels on Chicago's Magnificent Mile is a proper declaration of intent, especially in a retail district that has endured plenty of empty-window handwringing and big-brand churn....

Continue Reading
Stand Takes Colorado Bet on Wildfire-Smart Coverage

Updated Category News Views 21

Colorado’s insurance mess has finally attracted a company willing to price the driveway, the vents, and the tree line instead of shrugging at an entire ZIP code. Stand has launched homeowners coverage across the state, including mountain communities where wildfire exposure has made insurance both costly and scarce. This is not a small problem dressed up with a shiny...

Continue Reading
Vertiv's 800 VDC Push Gives AI Builders More Choices

Updated Category News Views 192

Electricity is becoming the awkward roommate inside every serious AI buildout, and Vertiv is trying to move it out of the rack before it eats the whole house. The company has expanded its 800 VDC offering beyond the PowerDirect 5000 rack product introduced in May 2026, laying out systems for the rack, the AI compute pod, and the full data hall. For investors following...

Continue Reading
Lennar Faces Legal Heat Over Alleged Misleading Statements

Updated Category News Views 152

Rumbling Legal Drama with Lennar Corporation Every trader knows the uneasy feeling when a stock you're eyeing takes a surprising nosedive on some legal muck coming out of the woodwork. Well, it's Lennar Corporation's turn in the spotlight for all the wrong reasons. They're getting slapped with a class action lawsuit by investors claiming the company pulled a fast one...

Continue Reading
OFRM Faces Legal Heat Over Toddler Snack Recall

Updated Category News Views 200

OFRM Under the Microscope: Who Saw This Coming? Smack dab in the middle of navigating everyday market volatility, here's Once Upon A Farm (NYSE: OFRM) taking the spotlight—but for all the wrong reasons. The company got slapped with a stark FDA warning. Their Tractor Wheels toddler snacks allegedly pose a choking risk— think 'dry, sticky mass' refusing to budge with...

Continue Reading
Amdocs Faces a Storm: Investor Alert as Legal Probe Begins

Updated Category News Views 64

Amdocs' Recent Crisis: What Investors Need to Know Lately, it seems Amdocs Limited (NASDAQ: DOX) has found itself knee-deep in a situation that could make seasoned investors cringe. November shone some harsh light on the company's operations, a move that’s attracted attention from Schall, Brown & Schwartz LLP (“SBS”), a name not exactly foreign to shareholder...

Continue Reading
Wall Street Gains Hold Amid Volatility Drop

Updated Category News Views 66

A Week of Gains and Regulatory Moves Right out of the gate, it’s been a decent stretch for Wall Street. Weekly gains kept the party going, even as traders navigated the usual hurdles. Stocks finished the week with a solid performance—all the heavy hitters like Dow, S&P 500, Nasdaq, and Russell 2000 ended on a high note, waltzing uphill past where many imagined...

Continue Reading
TYYY Liquidation Leaves Holders With a Tight Exit Window

Updated Category News Views 79

A fund can vanish faster than investors can read the fine print, and TYYY is doing exactly that. Exchange Traded Concepts has approved the closure and liquidation of the xETFs TSLA Daily Income ETF, with the fund expected to cease operations and distribute cash on or about November 20, 2026. This is not a debate about whether holders should love or hate Tesla. The product...

Continue Reading

Top 5 Most Recently Viewed Articles

ADT Inc. Pricing for Secondary Offering and Share Repurchase

Updated Category News Views 210

ADT Inc. Moves Forward with Secondary Public Offering ADT Inc. (NYSE: ADT) has made waves in the financial world by announcing the pricing of a secondary public offering. This significant event involves 56 million shares of common stock that are being sold by certain entities associated with Apollo Global Management, Inc. The process is designed to provide liquidity and...

Continue Reading
Exciting Updates from illumin Holdings Regarding Q2 2025 Results

Updated Category News Views 176

Upcoming Financial Results Announcement Toronto and New York - illumin Holdings Inc. (TSX: ILLM, OTCQB: ILLMF), renowned in the digital advertising technology sector, is gearing up to present its second quarter 2025 financial outcomes. These results are set to be unveiled before market operations commence on an announced date. Join Us for the Live Webcast All interested...

Continue Reading
Exploring Growth in the Mining Remanufacturing Sector

Updated Category News Views 168

Understanding the Mining Remanufacturing Components Market This comprehensive analysis provides insights into the growth of the mining remanufacturing components market. It highlights the increasing demand for sustainable practices, innovations, and market dynamics. Market Size and Growth Rate The mining remanufacturing components market was valued at around US$ 4.20...

Continue Reading
Novo Nordisk's Wegovy Trial Success: Weight Loss Breakthrough

Updated Category News Views 787

Groundbreaking Results from Novo Nordisk's Wegovy® Trial The latest findings from Novo Nordisk indicate a significant breakthrough in weight management through the higher dose of Wegovy, which has delivered an impressive average weight loss of 21% for individuals suffering from obesity. The trial results, presented at a prominent diabetes conference, revealed that...

Continue Reading
Builders FirstSource Announces Leadership Transition Plans

Updated Category News Views 230

Leadership Changes at Builders FirstSource Builders FirstSource, Inc. (NYSE: BLDR) is undergoing a major leadership shift as part of a planned transition. The company has announced that Peter Jackson, who currently serves as the Chief Financial Officer, will step into the role of President and Chief Executive Officer. This change marks an important milestone in the...

Continue Reading